Zubitrex TM 500mg/62.25mg Injection
By Zubitrex TM
Rx
1 Injection in a Vial

Composition
Ceftriaxone(500mg) + Tazobactum(62.25mg)

Manufacturer - PRM Life Sciences Pvt Ltd
SCF No. 415, 1st Floor, Motor Market Manimajra, Chandigarh -160101,India

Expires on or after
July, 2026

liver
When it comes to the safety of Zubitrex TM 500mg/62.25mg Injection in relation to liver health, it is important to exercise caution, especially for individuals with severe liver disease. In such cases, it may be necessary to adjust the dosage of Zubitrex TM 500mg/62.25mg Injection. It is crucial to consult your doctor before using this medication if you have severe liver issues. However, for patients with mild to moderate liver disease, dose adjustment of Zubitrex TM 500mg/62.25mg Injection is not usually recommended. Always seek medical advice and guidance to ensure the safe use of this injection in the presence of liver conditions.

kidney
Limited information is available on the use of Zubitrex TM 500mg/62.25mg Injection in patients with kidney disease. Please consult your doctor for guidance.

alcohol
It is safe to consume alcohol with Zubitrex TM 500mg/62.25mg Injection without causing harmful side effects.

driving
Zubitrex TM 500mg/62.25mg Injection may reduce alertness, impact vision, cause drowsiness, or dizziness. Avoid driving if experiencing these effects.

pregnancy
Zubitrex TM 500mg/62.25mg Injection is generally considered safe in pregnancy. Animal studies show minimal harmful effects, but human data is limited.

breastfeeding
Zubitrex TM 500mg/62.25mg Injection should be used carefully during breastfeeding. It is recommended to wait until the mother's treatment is finished and the drug has cleared from her system before resuming breastfeeding.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | ANTI INFECTIVES |
| Action Class | - |
₹98
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024
